| Schedule of consolidated statement of financial position |
|
|
|
As at
December 31, 2020
|
| |
|
Reported
|
|
Restated
|
|
Warrant liabilities
|
|
$
|
|
|
|
$
|
19,061 |
|
|
Current liabilities
|
|
|
10,164 |
|
|
|
29,225 |
|
|
Total liabilities
|
|
|
51,567 |
|
|
|
70,628 |
|
|
Additional paid-in capital
|
|
|
194,105 |
|
|
|
164,264 |
|
|
Accumulated deficit
|
|
|
(79,794 |
)
|
|
|
(69,014 |
)
|
|
Total shareholders’ equity
|
|
|
114,311 |
|
|
|
95,250 |
|
|
|
|
Year Ended
December 31, 2020
|
| |
|
Reported
|
|
Restated
|
|
Revenue
|
|
$
|
12,117 |
|
|
$
|
12,117 |
|
|
Loss from operations
|
|
|
(28,528 |
)
|
|
|
(28,528 |
)
|
|
Gain on remeasurement of warrant liabilities
|
|
|
|
|
|
|
10,780 |
|
|
Net loss
|
|
|
(36,675 |
)
|
|
|
(25,895 |
)
|
|
Net loss attributable to common shareholder – basic and diluted
|
|
|
(46,894 |
)
|
|
|
(36,114 |
)
|
|
Basic and diluted earnings per share
|
|
|
(4.34 |
)
|
|
|
(3.34 |
)
|
|
|
|
Year Ended
December 31, 2020
|
| |
|
Reported
|
|
Restated
|
|
Net loss
|
|
$
|
(36,675 |
)
|
|
$
|
(25,895 |
)
|
|
Gain on remeasurement of warrant liabilities
|
|
|
|
|
|
|
10,780 |
|
|
Net cash used in operating activities
|
|
|
(21,961 |
)
|
|
|
(21,961 |
)
|
|
|
|
Year Ended
December 31, 2020
|
| |
|
Reported
|
|
Restated
|
|
Business combination and PIPE financing
|
|
$
|
77,635 |
|
$
|
47,794 |
|
Total shareholders’ equity
|
|
|
114,311 |
|
|
95,250 |
|